Related Experiment Videos
HIV-1 coreceptor usage, transmission, and disease progression
1David Axelrod Institute, New York State Department of Health, 120 New Scotland Ave., Albany, NY 12208, USA. philpott@wadsworth.org
Current HIV Research
|March 27, 2004
Summary
Human immunodeficiency virus type 1 (HIV-1) coreceptor usage, specifically CCR5 or CXCR4, impacts disease progression. Understanding this relationship is key to developing effective HIV therapies.
Area of Science:
- Virology
- Immunology
- Pathogenesis
Background:
- HIV-1 entry into host cells requires CD4 and a coreceptor, typically CCR5 or CXCR4.
- Transmitted HIV-1 strains usually utilize CCR5 (R5 viruses), associated with stable infection.
- CXCR4-utilizing strains (X4 viruses) emerge later in infection in about 50% of individuals.
Purpose of the Study:
- To critically review recent studies on HIV-1 coreceptor usage.
- To examine the relationship between coreceptor tropism, transmission, CD4+ T-cell depletion, and disease progression.
- To elucidate the mechanisms linking X4 virus infection to accelerated HIV-1 disease progression.
Main Methods:
- Literature review of studies published in recent years.
- Analysis of research investigating HIV-1 coreceptor usage (CCR5 vs. CXCR4).
- Examination of data on HIV-1 transmission, CD4+ T-cell counts, and disease progression rates.
Main Results:
- R5 viruses are generally associated with initial infection and stable disease.
- X4 viruses are linked to rapid CD4+ T-cell decline and accelerated disease progression.
- The precise mechanisms driving X4-associated accelerated progression remain incompletely understood.
Conclusions:
- HIV-1 coreceptor usage is a critical factor in pathogenesis and disease progression.
- Further research is needed to fully understand why X4 viruses accelerate disease.
- Distinguishing between proposed mechanisms is essential for advancing HIV-1 knowledge.